2025年8月21日，星帅尔(002860.SZ)发布2025年中报。 公司营业总收入为11.32亿元。归母净利润为1.22亿元。经营活动现金净流入为9868.72万元。 公司最新资产负债率为37.45%，较上季度资产负债率增加0.35个百分点。 公司最新毛利率为17.36%，较上季度毛利率减少2.96个百分点，较去年同期毛利率减少0.29个百分点。最新ROE为5.49%。 公司摊薄每股收益为0.37元。 公司最新总资产周转率为0.32次。最新存货周转率为2.70次。 公司股东户数为1.88万户，前十大股东持股数量为1.54亿股，占总股本比例为42.83%，前十大股东持股情况如下： | 序号 | 股东名称 | 持股 | | --- | --- | --- | | l | 陈丽娟 | 23.7 | | 2 | 杭州富阳星帅尔股权投资有限公司 | 10.8 | | 3 | 钱凌 | 1.40 | | 4 | 张坚 | 1.36 | | 5 | 江苏兆信私募基金管理有限公司-兆信集合1号私募证券投资基金 | 1.33 | | 6 | 孙华民 | 1.02 | | 7 | 交通银行股份有限公司-国泰金鹰增长灵活配置混 ...

公司摊薄每股收益为0.07元，较去年同报告期摊薄每股收益增加0.04元，实现2年连续上涨，同比较去年 同期上涨96.30%。 公司最新总资产周转率为0.51次。最新存货周转率为1.99次，较去年同期存货周转率增加0.13次，实现3 年连续上涨，同比较去年同期上涨7.02%。 2025年8月21日，宏盛华源(601096.SH)发布2025年中报。 公司营业总收入为49.05亿元。归母净利润为1.98亿元，较去年同报告期归母净利润增加9730.98万元， 实现2年连续上涨，同比较去年同期上涨96.30%。经营活动现金净流入为1.66亿元。 公司最新资产负债率为53.22%，较去年同期资产负债率减少1.57个百分点。 公司最新毛利率为11.91%，较上季度毛利率增加0.72个百分点，实现2个季度连续上涨，较去年同期毛 利率增加3.69个百分点，实现2年连续上涨。最新ROE为4.35%，较去年同期ROE增加2.00个百分点。 公司股东户数为8.62万户，前十大股东持股数量为20.21亿股，占总股本比例为75.54%，前十大股东持 股情况如下： | 序号 | 股东名称 | 持股比例 | | --- | --- | - ...

公司最新毛利率为16.84%，较上季度毛利率减少3.49个百分点，较去年同期毛利率减少6.44个百分点。 最新ROE为4.28%。 公司摊薄每股收益为0.29元。 公司最新总资产周转率为0.33次，较去年同期总资产周转率减少0.03次，同比较去年同期下降8.59%。 最新存货周转率为1.58次。 公司股东户数为1.93万户，前十大股东持股数量为1.22亿股，占总股本比例为74.37%，前十大股东持股 情况如下： | 序号 | 股东名称 | 持股比例 | | --- | --- | --- | | 丁 | 张孝金 | 51.08% | | 2 | 张孝保 | 9.73% | | 3 | 张晨晨 | 4.87% | | 4 | 徐州市铜山区众和商务信息服务中心(有限合伙) | 2.46% | | ર્ટ | 徐州市铜山区久泰商务信息服务中心(有限合伙) | 2.40% | | 6 | 张孝玉 | 1.22% | | 7 | 张孝银 | 1.22% | | 8 | 晋江壹点纳锦资产管理有限公司-壹点纳锦冠宏六期私募证券投资基金 | 0.53% | | 9 | 林新 | 0.48% | | 10 | 晋江壹点纳锦资产 ...

Core Insights - The company reported a total revenue of 159 million yuan for the first half of 2025, a decrease of 1.58 million yuan compared to the same period last year, representing a year-on-year decline of 0.99% [1] - The net profit attributable to shareholders was -3.52 million yuan, indicating a loss [1] - The net cash inflow from operating activities was -64.99 million yuan [1] Financial Metrics - The latest debt-to-asset ratio is 22.87%, an increase of 1.42 percentage points from the previous quarter [3] - The latest gross profit margin stands at 43.41% [3] - The return on equity (ROE) is -0.32% [3] - The diluted earnings per share (EPS) is -0.01 yuan [3] - The total asset turnover ratio remained flat compared to the same period last year, with a year-on-year decline of 2.14% [3] - The latest inventory turnover ratio is 4.45 times [3] Shareholder Structure - The number of shareholders is 10,200, with the top ten shareholders holding 155 million shares, accounting for 59.06% of the total share capital [3] - The largest shareholder is Tongce Medical Co., Ltd., holding 19.01% [3] - Other significant shareholders include Hangzhou Panyuan Investment Co., Ltd. at 15.33% and Xiamen Silicon Valley Shaohua No.1 Investment Partnership at 10.01% [3]

公司最新资产负债率为56.99%，较上季度资产负债率增加1.95个百分点。 公司最新毛利率为18.12%。最新ROE为9.78%。 公司摊薄每股收益为0.64元。 2025年8月21日，横店东磁(002056.SZ)发布2025年中报。 公司营业总收入为119.36亿元。归母净利润为10.20亿元。经营活动现金净流入为17.01亿元。 公司最新总资产周转率为0.48次。最新存货周转率为2.47次，较去年同期存货周转率减少0.93次，同比 较去年同期下降27.41%。 公司股东户数为8.69万户，前十大股东持股数量为9.78亿股，占总股本比例为60.11%，前十大股东持股 情况如下： | 序号 | 股东名称 | 持股比例 | | --- | --- | --- | | I | 横店集团控股有限公司 | 50.59% | | 2 | 香港中央结算有限公司 | 3.04% | | 4 | 何时金 横店集团东磁股份有限公司-第三期员工持股计划 | 1.64% 0.88% | | ર | 全国社保基金五零二组合 | 0.80% | | 6 | 中国农业银行股份有限公司-中证500交易型开放式指数证券投资基金 | 0.7 ...

Core Viewpoint - Yibai Pharmaceutical (600594.SH) reported a significant decline in revenue and net profit for the first half of 2025, indicating potential challenges in its operational performance [1][3]. Financial Performance - The company's total revenue for the first half of 2025 was 993 million yuan, a decrease of 175 million yuan compared to the same period last year, representing a year-on-year decline of 14.99% [1]. - The net profit attributable to shareholders was -19.90 million yuan, indicating a loss [1]. - Operating cash flow showed a net inflow of 171 million yuan, down by 32.54 million yuan from the same period last year, a decline of 16.02% year-on-year [1]. Profitability and Efficiency Metrics - The latest asset-liability ratio stood at 36.24%, an increase of 1.19 percentage points from the previous quarter and up 1.04 percentage points from the same period last year [3]. - The gross profit margin was reported at 60.65%, down by 1.79 percentage points compared to the previous year [3]. - The return on equity (ROE) was -0.81%, indicating negative returns for shareholders [3]. - The diluted earnings per share were -0.03 yuan [4]. - The total asset turnover ratio was 0.24 times, a decrease of 0.02 times year-on-year, reflecting a decline of 6.09% [4]. - The inventory turnover ratio was 0.66 times, down by 0.08 times from the previous year, representing a decline of 10.26% [4]. Shareholder Structure - The number of shareholders was reported at 46,200, with the top ten shareholders holding a total of 260 million shares, accounting for 32.83% of the total share capital [4]. - The largest shareholder, Dou Qiling, held 23.42% of the shares [4].

Core Insights - The company reported a total revenue of 307 million yuan for the first half of 2025, marking an increase of 45.9 million yuan compared to the same period last year, achieving a 17.6% year-on-year growth [1] - The net profit attributable to shareholders reached 108 million yuan, an increase of 40.1 million yuan from the previous year, reflecting a 59.01% year-on-year growth [1] - The net cash inflow from operating activities was 118 million yuan [1] Financial Metrics - The latest debt-to-asset ratio stands at 11.01% [3] - The gross profit margin is 49.68%, up 0.92 percentage points from the previous quarter, and has increased by 7.59 percentage points year-on-year [3] - The return on equity (ROE) is 6.64%, an increase of 2.14 percentage points compared to the same period last year [3] - The diluted earnings per share (EPS) is 0.64 yuan, up 0.24 yuan year-on-year, representing a 60% increase [3] - The total asset turnover ratio is 0.17 times, an increase of 0.01 times year-on-year, reflecting an 8.35% growth [3] - The inventory turnover ratio is 0.99 times [3] Shareholder Structure - The number of shareholders is 8,278, with the top ten shareholders holding a total of 90.09 million shares, accounting for 53.53% of the total share capital [3] - The largest shareholder is Wuhan Xiwang Biological Engineering Co., Ltd., holding 44.1% of the shares [3]

据证券之星公开数据整理，近期欧圣电气（301187）发布2025年中报。截至本报告期末，公司营业总收 入8.78亿元，同比上升18.89%，归母净利润1.15亿元，同比上升18.52%。按单季度数据看，第二季度营 业总收入3.53亿元，同比下降14.61%，第二季度归母净利润5353.75万元，同比下降1.43%。本报告期欧 圣电气公司应收账款体量较大，当期应收账款占最新年报归母净利润比达71.22%。 本次财报公布的各项数据指标表现一般。其中，毛利率34.42%，同比减4.61%，净利率13.1%，同比减 0.31%，销售费用、管理费用、财务费用总计1.41亿元，三费占营收比16.09%，同比增5.57%，每股净资 产5.91元，同比减23.07%，每股经营性现金流0.24元，同比减78.09%，每股收益0.45元，同比减14.93% | 项目 | 2024年中报 | 2025年中报 | 同比增幅 | | --- | --- | --- | --- | | 营业总收入(元) | 7.39 亿 | 8.78亿 | 18.89% | | 归母净利润(元) | 9709.92万 | 1.15亿 | 18.52% ...

Core Insights - The company reported a total revenue of 440 million yuan for the first half of 2025, an increase of 210 million yuan compared to the same period last year, marking a 91.53% year-on-year growth [1] - The net profit attributable to shareholders reached 30.69 million yuan, up by 37.82 million yuan from the previous year, achieving two consecutive years of growth [1] - The net cash inflow from operating activities was 56.70 million yuan, an increase of 54.57 million yuan year-on-year, also reflecting two consecutive years of growth [1] Financial Ratios - The latest debt-to-asset ratio stands at 18.97% [3] - The gross profit margin is 24.74%, which is an increase of 6.53 percentage points compared to the same period last year [3] - The return on equity (ROE) is 2.49%, up by 3.08 percentage points year-on-year [3] Earnings Per Share and Turnover Ratios - The diluted earnings per share is 0.20 yuan, an increase of 0.25 yuan compared to the same period last year, achieving two consecutive years of growth [3] - The total asset turnover ratio is 0.30 times, an increase of 0.14 times year-on-year, reflecting an 81.89% increase [3] - The inventory turnover ratio is 2.85 times, up by 0.46 times compared to the previous year, representing a 19.20% year-on-year increase [3] Shareholder Information - The number of shareholders is 8,831, with the top ten shareholders holding a total of 95.10 million shares, accounting for 62.61% of the total share capital [3] - The largest shareholder, Luo Xingshun, holds 34.33% of the shares [3]

2025年8月16日，乐心医疗(300562.SZ)发布2025年中报。 公司营业总收入为5.21亿元，较去年同报告期营业总收入增加2276.71万元，实现2年连续上涨，同比较去年同期上涨4.57%。归母净利润为4229.04万元，较 去年同报告期归母净利润增加744.07万元，实现3年连续上涨，同比较去年同期上涨21.35%。经营活动现金净流入为4825.39万元，较去年同报告期经营活动 现金净流入增加1538.43万元，实现2年连续上涨，同比较去年同期上涨46.80%。 公司最新资产负债率为33.31%，较上季度资产负债率减少1.64个百分点，较去年同期资产负债率减少2.67个百分点。 公司最新毛利率为35.00%。最新ROE为4.19%，较去年同期ROE增加0.82个百分点。 公司摊薄每股收益为0.19元，较去年同报告期摊薄每股收益增加0.03元，实现3年连续上涨，同比较去年同期上涨21.03%。 公司最新总资产周转率为0.35次，较去年同期总资产周转率增加0.03次，实现2年连续上涨，同比较去年同期上涨9.78%。最新存货周转率为4.06次，较去年 同期存货周转率增加0.58次，实现3年连续上涨，同比 ...